Featured Research

from universities, journals, and other organizations

Novel Treatment Reduces Swollen Livers

Date:
August 18, 2009
Source:
Radboud University Nijmegen Medical Centre
Summary:
A novel treatment strategy for patients with many cysts in their liver led to a surprising result. A six month treatment with a synthetic gastrointestinal hormone lanreotide significantly decreased swollen cystic livers by approximately five percent, compared to a 'wait and see' policy.

A novel treatment strategy for patients with many cysts in their liver led to a surprising result, reported in the online version of Gastroenterology by researchers from Radboud University Nijmegen Medical Centre, The Netherlands. A six month treatment with a synthetic gastrointestinal hormone lanreotide significantly decreased swollen cystic livers by approximately five percent, compared to a ‘wait and see’ policy.

Related Articles


At least five percent of the population has one or two cysts in the liver. Cysts are fluid-filled cavities. There are also many patients who have numerous cysts, which then is termed a polycystic liver. These cysts cause the liver to grow to four to six times its normal size. Until recently, surgery was the only possible treatment for these patients, but this approach leads to many complications, and the outcome is not always successful. Ultimately, these patients need a liver transplantation, but in view of the limited availability of organs, only few are actually transplanted.

Hepatologist Prof. Drenth, from Radboud University Nijmegen Medical Centre, commented: "In Nijmegen, we had experience with the administration of synthetic gastrointestinal hormones in two polycystic liver patients. This treatment resulted in significantly smaller liver cysts. This stimulated us to proceed to a randomized clinical trial in 54 polycystic liver patients from Nijmegen (The Netherlands) and Leuven (Belgium). Computer tomography indicated that the size of the average liver was 4.6 liters, at least three times the normal size. Twenty-seven patients received a monthly injection of lanreotide, and results were compared with 27 patients who received a placebo injection. After six months with lanreotide, the liver size was reduced by 2.9 percent, while that of the placebo group increased by 1.6 percent. Lanreotide worked best for patients with the largest livers."

This novel approach allows physicians to avoid the prospect of surgery. In the Netherlands there is an estimated group of 17,000 patients with polycystic livers, three quarters will face surgery because of their disease.


Story Source:

The above story is based on materials provided by Radboud University Nijmegen Medical Centre. Note: Materials may be edited for content and length.


Journal Reference:

  1. van Keimpema L, Nevens F, Vanslembrouck R, van Oijen M.G., Hoffmann A.L., Dekker H.M., de Man R.A., Drenth J.P. Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial. Gastroenterology, 2009; DOI: 10.1053/j.gastro.2009.07.052

Cite This Page:

Radboud University Nijmegen Medical Centre. "Novel Treatment Reduces Swollen Livers." ScienceDaily. ScienceDaily, 18 August 2009. <www.sciencedaily.com/releases/2009/08/090814101835.htm>.
Radboud University Nijmegen Medical Centre. (2009, August 18). Novel Treatment Reduces Swollen Livers. ScienceDaily. Retrieved April 1, 2015 from www.sciencedaily.com/releases/2009/08/090814101835.htm
Radboud University Nijmegen Medical Centre. "Novel Treatment Reduces Swollen Livers." ScienceDaily. www.sciencedaily.com/releases/2009/08/090814101835.htm (accessed April 1, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, April 1, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Liberia Sees Resurgence of Drug Trafficking as Ebola Wanes

Liberia Sees Resurgence of Drug Trafficking as Ebola Wanes

AFP (Apr. 1, 2015) The governments of Liberia and Sierra Leone have been busy fighting the menace created by the deadly Ebola virus, but illicit drug lords have taken advantage of the situation to advance the drug trade. Duration: 01:12 Video provided by AFP
Powered by NewsLook.com
Stigma Stalks India's Leprosy Sufferers as Disease Returns

Stigma Stalks India's Leprosy Sufferers as Disease Returns

AFP (Apr. 1, 2015) The Indian government declared victory over leprosy in 2005, but the disease is making a comeback in some parts of the country, with more than a hundred thousand lepers still living in colonies, shunned from society. Duration: 02:41 Video provided by AFP
Powered by NewsLook.com
7-Year-Old Girl Gets 3-D Printed 'robohand'

7-Year-Old Girl Gets 3-D Printed 'robohand'

AP (Mar. 31, 2015) Although she never had much interest in prosthetic limbs before, Faith Lennox couldn&apos;t wait to slip on her new robohand. The 7-year-old, who lost part of her left arm when she was a baby, grabbed it as soon as it came off a 3-D printer. (March 31) Video provided by AP
Powered by NewsLook.com
Solitair Device Aims to Takes Guesswork out of Sun Safety

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015) The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins